KIMBERLY NIEBRUGGE: Open Payments
NPI 1518281757 · VANDALIA, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$181 in 8 payments from 6 companies in 2025. Trend: 2023 $132 · 2024 $120 · 2025 $181
Food & beverage: $181
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 3 | $67 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $29 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $28 |
| Xeris Pharmaceuticals, Inc. | 1 | $21 |
| Janssen Pharmaceuticals, Inc | 1 | $19 |
| Esperion Therapeutics, Inc. | 1 | $18 |
Products named: Wegovy, JARDIANCE, CAPLYTA, GVOKE HYPOPEN, SPRAVATO, NEXLETOL, Ozempic.
Industry payments across IL — which companies pay providers there.
